170 related articles for article (PubMed ID: 17229867)
21. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of the activity of beta-lactams against Pseudomonas aeruginosa according to phenotypes of resistance].
Bert F; Briaud I; Branger C; Lambert-Zechovsky N
Pathol Biol (Paris); 1996 May; 44(5):329-32. PubMed ID: 8758469
[TBL] [Abstract][Full Text] [Related]
23. Performance of VITEK-2 Compact and overnight MicroScan panels for direct identification and susceptibility testing of Gram-negative bacilli from positive FAN BacT/ALERT blood culture bottles.
Quesada MD; Giménez M; Molinos S; Fernández G; Sánchez MD; Rivelo R; Ramírez A; Banqué G; Ausina V
Clin Microbiol Infect; 2010 Feb; 16(2):137-40. PubMed ID: 19778301
[TBL] [Abstract][Full Text] [Related]
24. Comparison of in vitro activities of levofloxacin, ciprofloxacin, ceftazidime, cefepime, imipenem, and piperacillin-tazobactam against aerobic bacterial pathogens from patients with nosocomial infections.
Huang SS; Lee SC; Lee N; See LC; Tsai MH; Shieh WB
J Microbiol Immunol Infect; 2007 Apr; 40(2):134-40. PubMed ID: 17446961
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Vitek2 and BD Phoenix in antimicrobial susceptibility testing of Acinetobacter baumannii and Pseudomonas aeruginosa.
Jekarl DW; Han SB; Kim YJ; Shin SH; Park KG; Park JJ; Han K; Park YJ
Diagn Microbiol Infect Dis; 2010 Aug; 67(4):384-6. PubMed ID: 20638609
[TBL] [Abstract][Full Text] [Related]
26. Comparison of workflow and accuracy of identification and antimicrobial susceptibility testing of clinical isolates of Enterobacteriaceae, Pseudomonas aeruginosa and enterococci by Vitek 2 and routine methods.
Rantakokko-Jalava K; Elo-Lehtonen E; Meurman O
APMIS; 2006 Jan; 114(1):43-9. PubMed ID: 16499660
[TBL] [Abstract][Full Text] [Related]
27. Different antimicrobial susceptibility testing methods to detect ertapenem resistance in Enterobacteriaceae: VITEK2, MicroScan, Etest, disk diffusion, and broth microdilution.
Lee M; Chung HS
J Microbiol Methods; 2015 May; 112():87-91. PubMed ID: 25794901
[TBL] [Abstract][Full Text] [Related]
28. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
29. [Comparison between agar dilution and three other methods for determining the susceptibility of 228 clinical isolates of non-fermenting gram-negative rods].
Gómez-Garcés JL; Aracil B; Gil Y
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):331-7. PubMed ID: 19406523
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial susceptibility testing of carbapenems: multicenter validity testing and accuracy levels of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates.
Steward CD; Mohammed JM; Swenson JM; Stocker SA; Williams PP; Gaynes RP; McGowan JE; Tenover FC
J Clin Microbiol; 2003 Jan; 41(1):351-8. PubMed ID: 12517872
[TBL] [Abstract][Full Text] [Related]
31. [Performance evaluation of VITEK 2 system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates].
Acuner IC; Bayramoğlu G; Birinci A; Cekiç Cihan C; Bek Y; Durupınar B
Mikrobiyol Bul; 2011 Jul; 45(3):411-21. PubMed ID: 21935774
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country.
Samuelsen O; Buarø L; Giske CG; Simonsen GS; Aasnaes B; Sundsfjord A
J Antimicrob Chemother; 2008 Apr; 61(4):827-30. PubMed ID: 18227087
[TBL] [Abstract][Full Text] [Related]
33. Performance of Vitek 2 in antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates with different mechanisms of beta-lactam resistance.
Mazzariol A; Aldegheri M; Ligozzi M; Lo Cascio G; Koncan R; Fontana R
J Clin Microbiol; 2008 Jun; 46(6):2095-8. PubMed ID: 18434562
[TBL] [Abstract][Full Text] [Related]
34. Drug susceptibility testing of clinical isolates of streptococci and enterococci by the Phoenix automated microbiology system.
Brigante GR; Luzzaro FA; Pini B; Lombardi G; Sokeng G; Toniolo AQ
BMC Microbiol; 2007 May; 7():46. PubMed ID: 17521437
[TBL] [Abstract][Full Text] [Related]
35. [Pseudomonas aeruginosa and beta-lactam antibiotics at the time of Europe].
Cavallo JD; Mérens A
Pathol Biol (Paris); 2008; 56(7-8):435-8. PubMed ID: 19019568
[TBL] [Abstract][Full Text] [Related]
36. Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital.
Sanders CC; Peyret M; Moland ES; Cavalieri SJ; Shubert C; Thomson KS; Boeufgras JM; Sanders WE
J Clin Microbiol; 2001 Jul; 39(7):2379-85. PubMed ID: 11427542
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic susceptibility and mechanisms of beta-lactam resistance among clinical strains of Pseudomonas aeruginosa: first report in Algeria.
Drissi M; Ahmed ZB; Dehecq B; Bakour R; Plésiat P; Hocquet D
Med Mal Infect; 2008 Apr; 38(4):187-91. PubMed ID: 18395380
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital.
Raja NS; Singh NN
J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906
[TBL] [Abstract][Full Text] [Related]
39. [Influence of the mixed inoculum on the species-identification and antimicrobial susceptibility test results by the automated microbial systems].
Higa M; Kisanuki K; Yamane N; Nakasone I
Rinsho Byori; 2008 Apr; 56(4):283-9. PubMed ID: 18516962
[TBL] [Abstract][Full Text] [Related]
40. Effect of applying the new Clinical and Laboratory Standards Institute ticarcillin/clavulanic acid, piperacillin, piperacillin/tazobactam and imipenem susceptibility breakpoints for Pseudomonas aeruginosa in Hong Kong.
Ho PL; Chow KH; Tse H; Cheng VC
Int J Antimicrob Agents; 2012 Sep; 40(3):280-1. PubMed ID: 22795656
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
